NCT05907954 2026-03-16
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
IDEAYA Biosciences
Phase 2 Active not recruiting
IDEAYA Biosciences
Eli Lilly and Company
Eli Lilly and Company
Nobelpharma
MetrioPharm AG
Pfizer
Nobelpharma
Pfizer